Journal of Acupuncture Research

Korean Acupuncture & Moxibustion Medicine Society (대한침구의학회)
권호 표지

Bee Venom Inhibits DU-145 Cell Proliferation Through Induction of Apoptosis

Bee Venom이 세포자멸사를 통해 DU-145 세포의 증식에 미치는 영향

  • Hur, Keun-Young (Dept. of Acupuncture & Moxibustion, College of Oriental Medicine, Kyungwon University) ;
  • Song, Ho-Sueb (Dept. of Acupuncture & Moxibustion, College of Oriental Medicine, Kyungwon University)
  • 허근영 (경원대학교 한의과대학 침구학교실) ;
  • 송호섭 (경원대학교 한의과대학 침구학교실)
  • Received : 2011.06.01
  • Accepted : 2011.06.15
  • Published : 2011.06.20
Download PDF
⟨ Previous Next ⟩

Abstract

목적 : 이 연구는 봉독이 세포자멸사 관련 단백질의 발현 조절을 통하여 세포자멸사를 유도하고 전립선 암세포주인 DU-145 세포의 성장을 억제하는지를 확인하고 해당 기전을 살펴보고자 하였다. 방법 : 봉독을 처리한 후 DU-145의 세포자멸사를 관찰하기 위해 TUNEL staining assay를 시행하였으며, 세포자멸사 조절단백질의 변동 관찰에는 western blot analysis를 시행하였다. 결과 : DU-145 세포에 봉독을 처리한 후, 세포자멸사의 유발, 세포자멸사 관련 단백질의 발현에 미치는 영향을 관찰하여 다음과 같은 결과를 얻었다. 1. DU-145 세포에서 봉독을 처리한 후 세포자멸사가 유도되어 세포성장이 억제되었다. 2. 세포자멸사 관련 단백질 중 분리된 pro-apoptotic proteins인 PARP, caspase-3, caspase-9은 유의한 증가를 나타내었다. 3. 세포자멸사 관련 단백질 중 분리된 anti-apoptotic proteins인 Bcl-2, p-AKT, XIAP, cIAP2는 유의한 감소를, MMP2, MMP13은 유의한 증가를 나타내었다. 결론 : 이상의 결과는 봉독이 인간 전립선 암세포주인 DU-145의 세포자멸사를 유발함으로써 전립선암세포 증식억제 효과가 있음을 입증한 것으로 전립선암의 예방과 치료에 대한 효과적인 치료제 개발에 도움이 될 것으로 기대된다.

Keywords

References

  1. Jemal A, Tiwari RC, Murray T et al. Cancer Statistics. CA Cancer J Clin 2005 ; 55 : 10-30. https://doi.org/10.3322/canjclin.55.1.10
  2. Schally AV, Comaru-Schally AM, Plonowski A et al. Peptide analogs in the therapy of prostate cancer. Prostate. 2000 ; 45 : 158-66. https://doi.org/10.1002/1097-0045(20001001)45:2<158::AID-PROS10>3.0.CO;2-K
  3. Sun M, Wang G, Paciga JE, Feldman RI, Yuan ZQ, Ma XL et al. AKT1/PKB alpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am J Pathol. 2001 ; 159(2) : 431-7. https://doi.org/10.1016/S0002-9440(10)61714-2
  4. Cai RZ, Qin Y, Ertl T et al. New pseudononapeptide bombesin antagonist with C-terminal LeuW (CH2N)Tac-NH2 showing high binding affinity to bombesin/GRP receptors on CFPAC-1 human pancreatic cancer cell line. Int J Oncol. 1995 ; 6 : 1165-72.
  5. Y Akao, S Kusakabe, Y Banno, M Kito, Y Nakagawa, K Tamiya-Koizumi, M Hattori, M Sawada, Y Hirabayasi, N Ohishi, Y Nozawa. Ceramide accumulation is independent of camptothecin- induced apoptosis in prostate cancer LNCaP cells. Biochem Biophys Res Commun. 2002 ; 294 : 363-70. https://doi.org/10.1016/S0006-291X(02)00462-X
  6. Y Akao, Y Banno, Y Nakagawa, N Hasegawa, TJ Kim, T Murate, Y Igarashi, Y Nozawa. High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecininduced up-regulation. Biochem Biophys Res Commun. 2006 ; 342 : 1284-90. https://doi.org/10.1016/j.bbrc.2006.02.070
  7. K Mizutani, K Matsumoto, N Hasegawa, T Deguchi, Y Nozawa. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells. Exp Oncol. 2006 ; 28 : 209-15.
  8. K Abdelmohsen, R Pullmann Jr, A Lal, HH Kim, S Galban, X Yang, JD Blethrow, M Walker, J Shubert, DA Gillespie, H Furneaux, M Gorospe. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol Cell. 2007 ; 25 : 543-57. https://doi.org/10.1016/j.molcel.2007.01.011
  9. YB Kwon, HJ Lee, HJ Han, WC Mar, SK Kang, OB Yoon, Beitz AJ, JH Lee. The water-soluble fraction of bee venom produces antinociceptive and anti-inflammatory effects on rheumatoid arthritis in rats. Life Sci. 2002 ; 71 : 191-204. https://doi.org/10.1016/S0024-3205(02)01617-X
  10. Holle L, Song W, Holle E, Wei Y, Wagner T, Yu X. A matrix metalloproteinase 2 cleavable melittin/avidin conjugate specifically targets tumor cells in vitro and in vivo. Int J Oncol. 2003 ; 22 : 93-8.
  11. HJ Park, YK Lee, HS Song, KJ Kim, DJ Son, JW Lee and JT Hong. Melittin inhibits human prostate cancer cell growth through induction of apoptotic cell death. J Toxicol Pub Health. 2006 ; 22(1) : 31-7.
  12. Keitaro K, Riyako O, Yasunori F, Nanako H, Yukihiro A, Yoshinori N, Takashi D, Masafumi I. A role for SIRT1 in cell growth and chemoresistance in prostate cancer PC3 and DU145 cells. Biochemical and Biophysical Research Communications. 2008 ; 373 : 423-8. https://doi.org/10.1016/j.bbrc.2008.06.045
  13. Lowe SW, Lin AW. Apoptosis in cancer. Carcinogenesis. 2000 ; 21 : 48595.
  14. Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Death receptor-induced cell death in prostate cancer. J Cell Biochem. 2004 ; 91 : 7099.
  15. Gurumurthy S, Vasudevan KM, Rangnekar VM. Regulation of apoptosis in prostate cancer. Cancer Metastasis Rev. 2001 ; 20 : 22543.
  16. Kantoff PW. New agents in the therapy of hormone-refractory patients with prostate cancer. Semin Oncol. 1995 ; 22(1) : 324.
  17. Simon HU, Haj-Heyia A, Levi Schaffer F. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000 ; 5 : 415-8. https://doi.org/10.1023/A:1009616228304
  18. Wyllie AH. The genetic regulation of apoptosis. Curr. Opin. Genet.Dev. 1995 ; 5(1) : 97-104. https://doi.org/10.1016/S0959-437X(95)90060-8
  19. Green DR, Reed JC. Mitochondria and Apoptosis. Science. 1998 ; 281 : 1309-12. https://doi.org/10.1126/science.281.5381.1309
  20. Thornberry NA, Lazbrik Y. Caspases : enemies within. Science. 1998 ; 281 : 1312-6. https://doi.org/10.1126/science.281.5381.1312
  21. Nachshon-Kedmi M, Yannai S, Fares FA. Induction of apoptosis in human prostate cancer cell line, PC3, by 3,3'-diindolylmethane through the mitochondrial pathway. Br J Cancer. 2004 ; 91 : 1358-63. https://doi.org/10.1038/sj.bjc.6602145
  22. Darmon AJ, Nicholson DW, Bleackley RC. Activation of the apoptotic proteaseCPP32 by cytotoxic T cell derived granzyme B. Nature. 1995 ; 377 : 446-8. https://doi.org/10.1038/377446a0
  23. Zu K, Ip C. Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells. Cancer Res. 2003 ; 63 : 6988-95.
  24. Singh AV, Xiao D, Lew KL, Dhir R, Singh SV. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis. 2004 ; 25 : 83-90.
  25. Nesterov A, Ivashchenko Y, Kraft AS. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers apoptosis in normal prostate epithelial cells. Oncogene. 2002 ; 21 : 1135-40. https://doi.org/10.1038/sj.onc.1205151
  26. Dasmahapatra GP, Didolkar P, Alley MC, Ghosh S, Sausville EA, Roy KK. In vitro combination treatment with perifosine and UCN-01 demonstrates synergism against prostate (PC-3) and lung (A549) epithelial adenocarcinoma cell lines. Clin Cancer Res. 2004 ; 10 : 5242-52. https://doi.org/10.1158/1078-0432.CCR-03-0534
  27. Sedlak TW, Oltvai ZN, Yang E et al. Multiple Bcl2 family members demonstrate selective dimerization with Bax. Proc. Natl. Acad. Sci. USA. 1995 ; 92 : 7834-8. https://doi.org/10.1073/pnas.92.17.7834
  28. Reed JC. Apoptosis-based therapies. Nat Rev Drug Discov. 2002 ; 1 : 11121.
  29. Cory S, Adams JM. The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer. 2002 ; 2 : 647-56.
  30. Benimetskaya L, Miller P, Benimetsky S et al. Inhibition of potentially anti-apoptotic proteins by antisense protein kinase C-alpha (Isis 3521) and antisense bcl-2 (G3139) phosphorothioate oligodeoxynucleotides: relationship to the decreased viability of T24 bladder and PC3 prostate cancer cells. Mol Pharmacol. 2001 ; 60 : 129630-7.
  31. Bettaieb A, Dubrez-Daloz L, Launay S et al. Bcl-2 proteins: targets and tools for chemosensitisation of tumor cells. Curr Med Chem AntiCancer Agents. 2003 ; 3 : 307-18. https://doi.org/10.2174/1568011033482396
  32. Pugazhenthi S, Nesterova A, Sable C, Heideich KA, Boxer LM, Heasley LE, Rensch JEB. Akt/ protein kinase B upregulates Bcl2 expression through cAMP-response element-binding protein. J Biol Chem. 2000 ; 275 : 10761-6. https://doi.org/10.1074/jbc.275.15.10761
  33. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Frarke TF, Stanbridge E, Frisch S, Reed JC. Regulation of cell death protease caspase-9 by phosphorylation. Science. 1998 ; 282 : 1318-21. https://doi.org/10.1126/science.282.5392.1318
  34. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE. The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 1998 ; 17 : 3247-59.
  35. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev. 1999 ; 13 : 239-52. https://doi.org/10.1101/gad.13.3.239
  36. Fini ME, Cook JR, Mohan R. Regulation of matrix metalloproteinase gene expression. Matrix Metalloproteinases (Edited by Parks WC Mecham RP). San Diego : Academic Press. 1998 ; 299-356.
  37. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases. Structure, function, and biochemistry. Circ Res. 2003 ; 92 : 827-39. https://doi.org/10.1161/01.RES.0000070112.80711.3D
  38. HS Lee, HS Song. Bee venom inhibits LNCaP cell proliferation through induction of apoptosis via inactivation of NF-$\kappa$B. Journal of Acupuncture and Moxibustion. 2007 ; 25(2) : 59-74.
  39. HJ Oh, HS Song. Bee Venom Inhibits PC-3 Cell Proliferation Through Induction of Apoptosis Via Inactivation of NF-$\kappa$B. Journal of Korean Acupuncture and Moxibustion. 2010 ; 27(3) : 1-13.